APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    University of Bern and the Netherlands Cancer Institute Use 3D Cell Cultures to Study about Cancer Therapy Resistance

    In a significant milestone, an international research team led by the University of Bern and the Netherlands Cancer Institute have developed 3D cell cultures (organoids) in which genes can be specifically changed.  

    University of Bern and the Netherlands Cancer Institute Use 3D Cell Cultures to Study about Cancer Therapy Resistance

    By

    Apac CIOOutlook | Thursday, January 01, 1970

    Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

    In a significant milestone, an international research team led by the University of Bern and the Netherlands Cancer Institute have developed 3D cell cultures (organoids) in which genes can be specifically changed. Such 3D cell cultures allow the study of genes which cause therapy resistants in breast cancer treatment. The finding is very likely to improve the use of targeted anti-cancer drugs in the future.

    Resistance to the anti-cancer drug used is a major cause of the death of the patients suffering from metastatic cancer. In order to cure cancer and minimize the risk of drug resistance, efficient cancer therapies should be used right from the initial stages of the disease. As of now, there is no suitable drug to destroy or minimize cancer drug resistance. In such a scenario, the research team has created 3D cell cultures to investigate the mechanisms of drug resistance in breast cancer cases to improve existing cancer treatment procedures.

    To identify the best therapy for an individual patient, the research team is working on identifying whether organoids are useful in elucidating the mechanisms of cancer therapy resistance. For this purpose, the researchers are culturing the tumor cells in a three-dimensional matrix and are complementing the culture medium with special growth factors. In order to find the effect on therapy response, specific genes in these 3D cell cultures can be modified using molecular scissors.

    The 3D cell cultures have several advantages when compared to traditional cell cultures as they grow much more efficiently in the Petri dish. They represent the typical cellular heterogeneity of cancer, with which the cell cultures develop, unlike the few selected tumor cells that grow under conventional cell culture environments and do not represent original cancer tumor.

    More in News

    Real-Time Insights Fueling Smarter Brand Strategies

    Real-Time Insights Fueling Smarter Brand Strategies

    Transforming Retail: The Impact of VR and AR in Asia Pacific

    Transforming Retail: The Impact of VR and AR in Asia Pacific

    Enhancing Customer Satisfaction through Omni-Channel Payments

    Enhancing Customer Satisfaction through Omni-Channel Payments

    AI's Role in Apac's Digital Transformation Journey

    AI's Role in Apac's Digital Transformation Journey

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/university-of-bern-and-the-netherlands-cancer-institute-use-3d-cell-cultures-to-study-about-cancer-therapy-resistance-nwid-4935.html